Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Levofloxacin Compared With Cefepime in Treating Cancer Patients With Fever and Neutropenia
This study is ongoing, but not recruiting participants.
Study NCT00020865 Information provided by National Cancer Institute (NCI)
First Received: July 11, 2001 Last Updated: May 9, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Fever, Sweats, and Hot Flashes
Infection
Leukemia
Lymphoma
Neutropenia
Additional conditions recognized in this trial
Communicable Diseases
Fever
Hot Flashes
Lymphoma, Large-Cell, Immunoblastic
Lymphoma, Non-Hodgkin
More general conditions related to this trial
Agranulocytosis
Body Temperature Changes
Hematologic Diseases
Immune System Diseases
Immunoproliferative Disorders
Leukocyte Disorders
Leukopenia
Lymphatic Diseases
Lymphoproliferative Disorders
Neoplasms
Neoplasms by Histologic Type
Signs and Symptoms
Interventions listed in this trial
cefepime hydrochloride
levofloxacin
Additional drug interventions recognized in this trial
Cefepime
Cephalosporins
Ofloxacin
More general drug interventions related to this trial
Anti-Bacterial Agents
Anti-Infective Agents
Anti-Infective Agents, Urinary
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Nucleic Acid Synthesis Inhibitors
Pharmacologic Actions
Renal Agents
Therapeutic Uses
Sponsors listed in this trial
Jonsson Comprehensive Cancer Center
National Cancer Institute (NCI)
Back to top of Main Content
